APA (7th ed.) Citation

Chiara Castrignano, Federica Di Scipio, Francesco Franco, Barbara Mognetti, & Giovanni Nicolao Berta. (2023). Reviving a Classic Antigen with a Cutting-Edge Approach: Nanobodies for HER2+ Breast Cancer. MDPI AG.

Chicago Style (17th ed.) Citation

Chiara Castrignano, Federica Di Scipio, Francesco Franco, Barbara Mognetti, and Giovanni Nicolao Berta. Reviving a Classic Antigen with a Cutting-Edge Approach: Nanobodies for HER2+ Breast Cancer. MDPI AG, 2023.

MLA (9th ed.) Citation

Chiara Castrignano, et al. Reviving a Classic Antigen with a Cutting-Edge Approach: Nanobodies for HER2+ Breast Cancer. MDPI AG, 2023.